These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 31527117)

  • 21. Lysosomal degradation products induce
    Newton P; Thomas DR; Reed SCO; Lau N; Xu B; Ong SY; Pasricha S; Madhamshettiwar PB; Edgington-Mitchell LE; Simpson KJ; Roy CR; Newton HJ
    Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6801-6810. PubMed ID: 32152125
    [No Abstract]   [Full Text] [Related]  

  • 22. Effector Protein Cig2 Decreases Host Tolerance of Infection by Directing Constitutive Fusion of Autophagosomes with the Coxiella-Containing Vacuole.
    Kohler LJ; Reed ShC; Sarraf SA; Arteaga DD; Newton HJ; Roy CR
    mBio; 2016 Jul; 7(4):. PubMed ID: 27435465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coxiella burnetii Lipopolysaccharide: What Do We Know?
    Abnave P; Muracciole X; Ghigo E
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29168790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular life of Coxiella burnetii in macrophages.
    Ghigo E; Pretat L; Desnues B; Capo C; Raoult D; Mege JL
    Ann N Y Acad Sci; 2009 May; 1166():55-66. PubMed ID: 19538264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A CsrA-Binding,
    Wachter S; Bonazzi M; Shifflett K; Moses AS; Raghavan R; Minnick MF
    J Bacteriol; 2019 Nov; 201(22):. PubMed ID: 31451541
    [No Abstract]   [Full Text] [Related]  

  • 26. History and prospects of Coxiella burnetii research.
    Hechemy KE
    Adv Exp Med Biol; 2012; 984():1-11. PubMed ID: 22711624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Host cell-free growth of the Q fever bacterium Coxiella burnetii.
    Omsland A; Cockrell DC; Howe D; Fischer ER; Virtaneva K; Sturdevant DE; Porcella SF; Heinzen RA
    Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4430-4. PubMed ID: 19246385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Galleria mellonella as an alternative model of Coxiella burnetii infection.
    Norville IH; Hartley MG; Martinez E; Cantet F; Bonazzi M; Atkins TP
    Microbiology (Reading); 2014 Jun; 160(Pt 6):1175-1181. PubMed ID: 24677067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Coxiella burnetii T4SS effector protein AnkG hijacks the 7SK small nuclear ribonucleoprotein complex for reprogramming host cell transcription.
    Cordsmeier A; Rinkel S; Jeninga M; Schulze-Luehrmann J; Ölke M; Schmid B; Hasler D; Meister G; Häcker G; Petter M; Beare PA; Lührmann A
    PLoS Pathog; 2022 Feb; 18(2):e1010266. PubMed ID: 35134097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of Early Stages of Human Alveolar Infection by the Q Fever Agent
    Dragan AL; Kurten RC; Voth DE
    Infect Immun; 2019 Mar; 87(5):. PubMed ID: 30833339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of OmpA, a Coxiella burnetii protein involved in host cell invasion, by multi-phenotypic high-content screening.
    Martinez E; Cantet F; Fava L; Norville I; Bonazzi M
    PLoS Pathog; 2014 Mar; 10(3):e1004013. PubMed ID: 24651569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biogenesis of the lysosome-derived vacuole containing Coxiella burnetii.
    Kohler LJ; Roy CR
    Microbes Infect; 2015; 17(11-12):766-71. PubMed ID: 26327296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dependency of
    Larson CL; Beare PA; Heinzen RA
    J Bacteriol; 2019 Dec; 201(23):. PubMed ID: 31501284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and characterization of arginine finger-like motifs, and endosome-lysosome basolateral sorting signals within the Coxiella burnetii type IV secreted effector protein CirA.
    Weber MM; Faris R; van Schaik EJ; Samuel JE
    Microbes Infect; 2018 May; 20(5):302-307. PubMed ID: 29331581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measuring pH of the Coxiella burnetii Parasitophorous Vacuole.
    Samanta D; Gilk SD
    Curr Protoc Microbiol; 2017 Nov; 47():6C.3.1-6C.3.11. PubMed ID: 29120485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated Cholesterol in the
    Mulye M; Samanta D; Winfree S; Heinzen RA; Gilk SD
    mBio; 2017 Feb; 8(1):. PubMed ID: 28246364
    [No Abstract]   [Full Text] [Related]  

  • 37. Host cell depletion of tryptophan by IFNγ-induced Indoleamine 2,3-dioxygenase 1 (IDO1) inhibits lysosomal replication of Coxiella burnetii.
    Ganesan S; Roy CR
    PLoS Pathog; 2019 Aug; 15(8):e1007955. PubMed ID: 31461509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studying Coxiella burnetii Type IV Substrates in the Yeast Saccharomyces cerevisiae: Focus on Subcellular Localization and Protein Aggregation.
    Rodríguez-Escudero M; Cid VJ; Molina M; Schulze-Luehrmann J; Lührmann A; Rodríguez-Escudero I
    PLoS One; 2016; 11(1):e0148032. PubMed ID: 26821324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurotransmitter System-Targeting Drugs Antagonize Growth of the Q Fever Agent, Coxiella burnetii, in Human Cells.
    Fullerton MS; Colonne PM; Dragan AL; Brann KR; Kurten RC; Voth DE
    mSphere; 2021 Aug; 6(4):e0044221. PubMed ID: 34232075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coxiella burnetii effector CvpB modulates phosphoinositide metabolism for optimal vacuole development.
    Martinez E; Allombert J; Cantet F; Lakhani A; Yandrapalli N; Neyret A; Norville IH; Favard C; Muriaux D; Bonazzi M
    Proc Natl Acad Sci U S A; 2016 Jun; 113(23):E3260-9. PubMed ID: 27226300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.